AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30946967
Drug: Polyethylene Glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene Glycol (PEG) syrup (1 mL/kg body weight/day for 1 month)
Trial: 28672136
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of propofol and midazolam (PM group)
Trial: 27240438
Drug: Control (antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (antiarrhythmic pharmacologic therapy)
Trial: 19695832
Drug: Nutritional therapy
RxNorm normalized name: nutritional therapy for GSD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional therapy group (NT group) received individual nutritional counseling and interventions, including oral nutritional supplements if appropriate.
Trial: 19695832
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplement group (ONS group) received oral nutritional supplements in addition to hospital meals without further instruction or counseling.
Trial: 19695832
Drug: Nutritional therapy
RxNorm normalized name: nutritional therapy for GSD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional therapy group (NT group)
Trial: 19695832
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplement group (ONS group)
Trial: 8750403
Drug: PGE1 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE1 at 0.06 micro g/kg per minute for 3 postoperative days
Trial: 18987553
Drug: Buspirone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (20 mg)
Trial: 6130065
Drug: Clorazepate (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clorazepate (24 mg)
Trial: 31891449
Drug: roxadustat (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxadustat (initial dose, 50 or 70 mg) for 24 weeks (ESA-Naïve Study)
Trial: 31891449
Drug: roxadustat (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxadustat (initial dose, 70 or 100 mg based on prior ESA dose) for 52 weeks (ESA-Converted Study)
Trial: 27975236
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 at 10,000 IU daily
Trial: 27975236
Drug: Low-dose vitamin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vitamin D3 at 1000 IU daily
Trial: 27975236
Drug: Both high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both high-dose and low-dose vitamin D3
Trial: 24400643
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group receiving a half-day training in heart failure management and structured up-titration scheme.
Trial: 19219569
Drug: HHH therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HHH therapy administered over 3-9 days
Trial: 17283283
Drug: Flumazenil (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.9 mg intravenous bolus followed by 0.0102 mg/min infusion)
Trial: 11680670
Drug: Omeprazole MUPS
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole MUPS 20 mg tablet (Test)
Trial: 11680670
Drug: Omeprazole MUPS
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole MUPS 20 mg tablet (Reference)
Trial: 11680670
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (Test and Reference)
Trial: 27913872
Drug: 4 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g/day of fish oil (2.4 g n-3 PUFA)
Trial: 25765839
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of Erigerontis hydroxybenzenes injection (EHI)
Trial: 25765839
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of EHI
Trial: 19756742
Drug: Doxycycline treatment
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline treatment for 6 weeks
Trial: 7835264
Drug: Intraumbilical infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraumbilical infusion through a mucus aspiration catheter
Trial: 7835264
Drug: Intraumbilical infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraumbilical infusion by an 18 gauge needle (direct injection)
Trial: 26973347
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rivaroxaban OD for 45 days
Trial: 26973347
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg fondaparinux OD for 45 days
Trial: 15753273
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (0.6 mg/kg, max 10 mg)
Trial: 12531351
Drug: Outer membrane
RxNorm normalized name: Outer membrane protein 3B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outer membrane vesicle (OMV) vaccines
Trial: 3565812
Drug: Neostigmine (0.005,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (0.005, 0.01, 0.02 or 0.05 mg/kg)
Trial: 3565812
Drug: Pyridostigmine (0.02,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine (0.02, 0.04, 0.1, or 0.2 mg/kg)
Trial: 3565812
Drug: Edrophonium (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium (0.1, 0.2, 0.4 or 1 mg/kg)
Trial: 31273506
Drug: Hyaluronan formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronan formulation (study cream, S)
Trial: 31273506
Drug: Control cream
RxNorm normalized name: BENZOYL PEROXIDE 3 mg in 60 mL TOPICAL LIQUID [Acnecare Dermacontrol Cream]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control cream (placebo, P)
Trial: 22796108
Drug: Modafinil, 200
RxNorm normalized name: Modafinil, 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil, 200 mg, once daily
Trial: 22796108
Drug: Escitalopram, 20
RxNorm normalized name: Escitalopram, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram, 20 mg, once daily
Trial: 22796108
Drug: Modafinil +
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil + Escitalopram, once daily
Trial: 16798442
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with intermittent 10‐mL boluses of 0.125% levobupivacaine into the epidural space and physiologic saline into the surgical wound
Trial: 16798442
Drug: Incisional analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incisional analgesia with intermittent 10‐mL boluses of 0.25% levobupivacaine into the wound and epidural saline
Trial: 10762286
Drug: Quinagolide (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinagolide (0.075 to 0.6 mg/day)
Trial: 10762286
Drug: Cabergoline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5 to 3 mg/week)
Trial: 26716357
Drug: Controlled-inhalation nebulizer
RxNorm normalized name: Hydra-Neb Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-inhalation nebulizer (AKITA)
Trial: 22759069
Drug: RIT (regenerative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT (regenerative injection therapy)
Trial: 22759069
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy only
Trial: 22759069
Drug: RIT after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT after exercise therapy
Trial: 18482589
Drug: G-FOBT (Hemoccult-II)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-FOBT (Hemoccult-II)
Trial: 16518579
Drug: Prednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (10 mg/day)
Trial: 16518579
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg/day) and Prednisolone (10 mg/day)
Trial: 12901730
Drug: Oral nicorandil-induced
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nicorandil-induced lesions
Trial: 11180878
Drug: 6.9% branched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.9% branched chain amino acid (BCAA) solution
Trial: 29899395
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy with cisplatin (50 mg/m2) and etoposide (100 mg/m2) followed by intravenous chemotherapy
Trial: 29899395
Drug: Intravenous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous chemotherapy alone
Trial: 29899395
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy with cisplatin and etoposide
Trial: 18237663
Drug: Intravenous catheter
RxNorm normalized name: intravenous catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous catheter collection technique
Trial: 16247245
Drug: Deep Relief
RxNorm normalized name: SALICYLIC ACID 2 g in 100 mL TOPICAL SOLUTION [Deep Relief Acne (Blemish) Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep Relief gel (3% menthol)
Trial: 16247245
Drug: Ibuleve gel
RxNorm normalized name: Ibuleve
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuleve gel (only ibuprofen)
Trial: 11885181
Drug: HA-coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-coated implants
Trial: 11885174
Drug: Non-HA implants
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-HA implants
Trial: 11885174
Drug: HA-grooved implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-grooved implant
Trial: 8599319
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg beta-carotene supplementation
Trial: 1568865
Drug: Inhaled ketanserin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ketanserin, 10 mg given 30 min before test
Trial: 27631883
Drug: Percent time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percent time with NT-proBNP ≥1000 pg/mL (serial measurement)
Trial: 25624376
Drug: Oropharyngeal colostrum
RxNorm normalized name: COLOSTRUM
DrugBank: Human colostrum (DB19286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal colostrum administration (0.2 mL every 3 hours for 3 days)
Trial: 20049961
Drug: Oral rapamycin
RxNorm normalized name: kanamycin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rapamycin (2 mg/day for 30 days)
Trial: 18509181
Drug: Fluorouracil, irinotecan,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorouracil, irinotecan, and oxaliplatin (first-line combination chemotherapy)
Trial: 14520110
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone propionate (FP, Flonase)
Trial: 1441867
Drug: Thiopentone 5‐6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 5‐6 mg/kg
Trial: 1441867
Drug: Propofol 2‐3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2‐3 mg/kg
Trial: 23757968
Drug: Tadalafil combined
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil combined with behavior therapy
Trial: 16714425
Drug: 160/12.5 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160/12.5 mg valsartan/hydrochlorothiazide (HCTZ)
Trial: 18227782
Drug: Interpersonal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal and social rhythm therapy
Trial: 11256459
Drug: Psychoeducation, group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducation, group therapy, couples therapy, family therapy, interpersonal psychotherapy
Trial: 7943089
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone (10 mg, 10 mg, 5 mg, 5 mg) administered in four doses at 12-hour intervals over 36 hours
Trial: 2975609
Drug: Celiprolol 200-600
RxNorm normalized name: celiprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 200-600 mg daily
Trial: 2975609
Drug: Chlorthalidone 12.5-37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 12.5-37.5 mg daily
Trial: 28286289
Drug: 8mg intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8mg intravenous zolpidem
Trial: 18518938
Drug: Levamisole group
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole group (100 mg levamisole p.o. after each haemodialysis session)
Trial: 16598663
Drug: Men with
RxNorm normalized name: Peptamen with Prebio Vanilla
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men with offences against biological daughters or stepdaughters
Trial: 10890312
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lithium carbonate for 10 days and 30 mg mirtazapine on day 9
Trial: 10890312
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules and 30 mg mirtazapine on day 9
Trial: 10890312
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mirtazapine and lithium
Trial: 1383416
Drug: recombinant interferon
RxNorm normalized name: Recombinant Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant interferon treatment
Trial: 31211741
Drug: Anastrozole or
RxNorm normalized name: anastrozole Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole or exemestane (5 years of adjuvant therapy)
Trial: 30112584
Drug: Interventional care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interventional care (up-titrated antihypertensive therapy with a single pill combination of olmesartan, amlodipine, and/or hydrochlorothiazide in 4-week intervals)
Trial: 30112584
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (treatment according to the 2013 European Society of Cardiology guidelines)
Trial: 8629744
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus diclofenac (150 mg)
Trial: 8629744
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus diclofenac (150 mg)
Trial: 2899107
Drug: Alcoholic preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcoholic preparations (n-propanol and isopropanol)
Trial: 2899107
Drug: Povidone-iodine detergent
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine detergent preparations
Trial: 2899107
Drug: Alcoholic formulations
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholic formulations
Trial: 26876066
Drug: ICG-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICG-guided therapy (HD)
Trial: 26876066
Drug: Empiric therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric therapy (GE)
Trial: 22399096
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of 50 mg losartan and 12.5 mg HCTZ (n=109)
Trial: 22399096
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy with 100 mg losartan (n=107)
Trial: 16188740
Drug: Positive expiratory
RxNorm normalized name: AerobiKA Oscillating Positive Expiratory Pressure Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive expiratory pressure (PEP) treatment
Trial: 16188740
Drug: PEP treatment
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEP treatment (repeated tests)
Trial: 12462872
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment (Nd:YAG-laser with water spray)
Trial: 10497848
Drug: BHAC-DM (daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BHAC-DM (daunorubicin 40 mg/m2/day x 4 or more, behenoyl cytarabine 200 mg/m2/day x 10 or more, 6-mercaptopurine 70 mg/m2/day x 10 or more)
Trial: 10497848
Drug: BHAC-EDM (daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BHAC-EDM (daunorubicin 40 mg/m2/day x 4 or more, behenoyl cytarabine 200 mg/m2/day x 10 or more, 6-mercaptopurine 70 mg/m2/day x 10 or more, etoposide 100 mg/m2/day x 5)
Trial: 8756388
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy after the fifth chemotherapy cycle
Trial: 2006875
Drug: Piritrexim 50
RxNorm normalized name: Piritrexim
DrugBank: Piritrexim (DB03695)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piritrexim 50 mg or more twice daily
Trial: 2006875
Drug: Piritrexim (dosages
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piritrexim (dosages ranged from 25 to 100 mg twice a day)
Trial: 31021880
Drug: Carbohydrate-rich drink
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-rich drink (200 ml) 2 to 3 hours before surgery
Trial: 24443305
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg piracetam
Trial: 20665424
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation at nutritional doses
Trial: 17052819
Drug: Recombinant NspA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant NspA vaccine (rNspA)
Trial: 17052819
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available quadravalent meningococcal polysaccharide vaccine (Menomune)
Trial: 11814097
Drug: PMX-F treatment
RxNorm normalized name: F-15599
DrugBank: F-15599 (DB16936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMX-F treatment (n=7)
Trial: 11814097
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (n=7)
Trial: 2707929
Drug: Nesosteine (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nesosteine (900 mg/day)
Trial: 782135
Drug: Intranasal beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal beclomethasone dipropionate (Becotide) 300 mug/day
Trial: 23062791
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) - flexible morning dose (30, 50, 70 mg/day)
Trial: 19288980
Drug: Cow's milk
RxNorm normalized name: Cow's milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cow's milk (CM) desensitization protocol, starting with one drop of whole CM diluted 1:25, doubled weekly for 18 weeks to achieve 200 mL intake.
Trial: 16817084
Drug: Levobupivacaine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (7 ml of 5 mg/ml)
Trial: 16817084
Drug: Control (physiologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (physiologic saline solution)
Trial: 12629559
Drug: Twice-weekly supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly supervised strength training for 15 weeks followed by 6 months of unsupervised training
Trial: 12473477
Drug: Cefazolin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (1 g)
Trial: 8491103
Drug: Drugs that
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs that modulate sleep, such as tricyclic antidepressants
Trial: 8491103
Drug: Other agents
RxNorm normalized name: Other agents for local oral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other agents affecting central nervous system neurotransmitters, particularly serotonin
Trial: 10848657
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg b.d.
Trial: 21828378
Drug: Cediranib 20
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 20 mg plus mFOLFOX6
Trial: 21828378
Drug: Cediranib 30
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 30 mg plus mFOLFOX6
Trial: 15017668
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy without susceptibility testing